This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: New York University, University of Southern California. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: Innovator Spotlight: Brooke Bullock Lau
Introduction
Brooke Bullock Lau is an accomplished inventor located in Leesville, South Carolina. With a strong focus on biomedical innovations, she has made significant contributions to the field of gene expression regulation. Her patent work demonstrates not only her creativity but also her commitment to advancing medical research and treatment options.
Latest Patents
Brooke Bullock Lau holds one patent titled "Control of Hypoxia-Inducible Gene Expression with Oligooxopiperazine Nonpeptidic Helix Mimetics." This invention revolves around oligooxopiperazines that are designed to mimic helix αB of the C-terminal transactivation domain of HIF-1α. The patent encompasses pharmaceutical compositions that include these oligooxopiperazines and outlines various methods for their application. Such methods aim to reduce gene transcription, treat or prevent disorders linked to the interaction of HIF-1α with CREB-binding protein and/or p300, curb angiogenesis in tissues, induce apoptosis, and decrease cell survival and/or proliferation.
Career Highlights
Throughout her career, Brooke has worked at prominent institutions, including New York University and the University of Southern California. Her experience at these esteemed organizations has not only enriched her expertise but has also provided her with valuable insights into the intersection of research and innovation.
Collaborations
Collaboration has been a key aspect of Brooke Lau's professional journey. She has had the opportunity to work alongside notable colleagues such as Paramjit S. Arora and Bogdan Z. Olenyuk. These partnerships have likely contributed to her innovative endeavors and the successful development of her patent.
Conclusion
Brooke Bullock Lau exemplifies the spirit of innovation with her focus on gene expression regulation and her dedication to improving medical treatment options. Her patent on oligooxopiperazines demonstrates her contributions to the field and highlights the potential applications of her work. As she continues to collaborate and push boundaries in her research, Brooke remains an inspiring figure for future inventors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile